Correction: Management of relapsed and refractory multiple myeloma: novel agents, antibodies, immunotherapies and beyond.
Leukemia
; 33(4): 1058-1059, 2019 Apr.
Article
en En
| MEDLINE
| ID: mdl-30842604
ABSTRACT
Following the publication of this article the authors noted that the MRD data under the Table 1 column "Remark" of Aspire should go to that of Pollux. The authors wish to apologize for any inconvenience caused. The corrected table is attached to this correction.
Texto completo:
1
Base de datos:
MEDLINE
Idioma:
En
Revista:
Leukemia
Asunto de la revista:
HEMATOLOGIA
/
NEOPLASIAS
Año:
2019
Tipo del documento:
Article